Familial hemophagocytic lymphohistiocytosis (FHL) is a potentially lethal genetic disorder of immune dysregulation that requires prompt and accurate diagnosis to initiate life-saving immunosuppressive therapy and to prepare for hematopoietic stem cell transplantation. In the present study, 85 patients with hemophagocytic lymphohistiocytosis were screened for FHL3 by Western blotting using platelets and by natural killer cell lysosomal exocytosis assay. Six of these patients were diagnosed with FHL3. In the acute disease phase requiring platelet transfusion, it was difficult to diagnose FHL3 by Western blot analysis or by lysosomal exocytosis assay. In contrast, the newly established flow cytometric analysis of
IntroductionThe granule-dependent cytotoxic pathway is a major immune effector mechanism used by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. 1 The pathway involves a series of steps, including cell activation, polarization of the lysosomal granules to the immunologic synapse, exocytosis of lytic proteins such as perforin and granzymes, and induction of apoptosis in the target cells. 2 In addition to its central role in the defense against intracellular infections and in tumor immunity, this pathway also plays an important role in the regulation of immune homeostasis. Defects in the granule-dependent cytotoxic pathway result in a catastrophic hyperinflammatory condition known as hemophagocytic lymphohistiocytosis (HLH). 1,3 HLH is a life-threatening syndrome of immune dysregulation resulting from the uncontrolled activation and proliferation of CTLs, which leads to macrophage activation and the excessive release of inflammatory cytokines. 4,5 Clinical diagnosis of HLH is made on the basis of cardinal signs and symptoms including prolonged fever and hepatosplenomegaly, and by characteristic laboratory findings such as pancytopenia, hyperferritinemia, hypofibrinogenemia, increased levels of soluble IL-2 receptor, and low or absent NK cell activity. 5,6 HLH can be classified into primary (genetic) or secondary (acquired) forms according to the underlying etiology, although this distinction is difficult to make in clinical practice. 4,5 Familial hemophagocytic lymphohistiocytosis (FHL) encompasses major forms of primary HLH for which mutations in the genes encoding perforin (PRF1; FHL2), 7 Munc13-4 (UNC13D; FHL3), 8 syntaxin-11 (STX11; FHL4), 9 and syntaxinbinding protein 2 (also known as Munc18-2) (STXBP2; FHL5) 10,11 have been identified to date. Perforin is a cytolytic effector that forms a pore-like structure in the target cell membrane. Munc13-4, syntaxin-11, and Munc18-2 are involved in intracellular trafficking or the fusion of cytolytic granules to the plasma membrane and the subsequent delivery of their contents into target cells. 1,12 Consequently, defective cytotoxic activity of CTLs and NK cells is one of the hallmark findings of FHL, 7,8,[13][14][15][16] although NK cell activity is also decreased in some cases of secondary HLH. 15,[17][18][19][20] Prompt and accurate diagnosis o...